|
Name |
Catechol
|
Molecular Formula | C6H6O2 | |
IUPAC Name* |
benzene-1,2-diol
|
|
SMILES |
C1=CC=C(C(=C1)O)O
|
|
InChI |
InChI=1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H
|
|
InChIKey |
YCIMNLLNPGFGHC-UHFFFAOYSA-N
|
|
Synonyms |
pyrocatechol; catechol; 120-80-9; 1,2-benzenediol; 1,2-dihydroxybenzene; benzene-1,2-diol; pyrocatechin; 2-hydroxyphenol; o-Benzenediol; o-Dihydroxybenzene; o-Dioxybenzene; o-Hydroquinone; o-Hydroxyphenol; Phthalhydroquinone; Pyrocatechine; o-Phenylenediol; Oxyphenic acid; Fouramine PCH; benzenediol; Durafur developer C; Pelagol Grey C; Catechin (phenol); Fourrine 68; Benzene, o-dihydroxy-; Catechol (phenol); o-Diphenol; C.I. Oxidation Base 26; Pyrokatechin; Pyrokatechol; Katechol; ortho-Dihydroxybenzene; NCI-C55856; NSC 1573; C.I. 76500; Catechol-pyrocatechol; 12385-08-9; MFCD00002188; LF3AJ089DQ; CHEMBL280998; DTXSID3020257; CHEBI:18135; NSC-1573; ortho-Hydroxyphenol; 26982-53-6; CAQ; DSSTox_CID_257; ortho-Benzenediol; ortho-Dioxybenzene; ortho-Hydroquinone; DSSTox_RID_75468; Katechol [Czech]; ortho-Phenylenediol; Pyrocatechinic acid; DSSTox_GSID_20257; Pyrokatechin [Czech]; Pyrokatechol [Czech]; Benzene-1,2-diol (Pyrocatechol); CI Oxidation Base 26; Phthalic alcohol; CAS-120-80-9; SMR000326660; CCRIS 741; HSDB 1436; EINECS 204-427-5; UNII-LF3AJ089DQ; BRN 0471401; Oxyphenate; CI 76500; Kachin; ortho-diphenol; benzene diol; ortho-Quinol; AI3-03995; 4oow; alpha-hydroxyphenol; 1,2-benzenedio; o-dihydroxy-benzene; phenol derivative, 2; 3fw4; 4k7i; CATECHOL [HSDB]; CATECHOL [IARC]; Pyrocatechol, >=99%; CATECHOL [VANDF]; Lopac-C-9510; PYROCATECHOL [MI]; WLN: QR BQ; bmse000385; EC 204-427-5; PYROCATECHOL [INCI]; 1,2-Dihydroxybenzene, XI; 1,2-Benzenediol; Catechol; Lopac0_000280; SCHEMBL18351; MLS002153385; MLS002303022; BIDD:ER0327; Pyrocatechinic acidPyrocatechol; Pyrocatechol, p.a., 99.0%; BDBM26188; Durafur Developer CFouramine PCH; NSC1573; HMS2233A17; HMS3260H22; HMS3373K16; Tox21_202317; Tox21_300153; Tox21_500280; s6305; STK398651; ZINC13512214; AKOS000119002; CCG-204375; DB02232; LP00280; SDCCGSBI-0050268.P002; NCGC00015283-01; NCGC00015283-02; NCGC00015283-03; NCGC00015283-04; NCGC00015283-05; NCGC00015283-06; NCGC00015283-07; NCGC00015283-08; NCGC00015283-10; NCGC00091262-01; NCGC00091262-02; NCGC00091262-03; NCGC00253952-01; NCGC00259866-01; NCGC00260965-01; AC-34196; BP-21156; BS-20054; Catechol (Pyrocatechol; Benzene-1,2-diol); DB-003770; C.I.-76500; EU-0100280; FT-0606411; P0317; P0567; EN300-19426; C 9510; C00090; C01785; D91943; 1,2-Dihydroxybenzene, ReagentPlus(R), >=99%; Pyrocatechol, purified by sublimation, >=99.5%; A804599; AB-131/40235236; Q282440; SR-01000075791; SR-01000075791-1; W-109068; F0001-0332; Pyrocatechol, certified reference material, TraceCERT(R); Z104473810; Pyrocatechol, plant cell culture tested, BioReagent, >=99%, powder; 2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-,(2R-trans)-
|
|
CAS | 120-80-9 | |
PubChem CID | 289 | |
ChEMBL ID | CHEMBL280998 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 110.11 | ALogp: | 0.9 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 40.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 8 | QED Weighted: | 0.497 |
Caco-2 Permeability: | -4.444 | MDCK Permeability: | 0.00002120 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.016 | 20% Bioavailability (F20%): | 0.957 |
30% Bioavailability (F30%): | 0.799 |
Blood-Brain-Barrier Penetration (BBB): | 0.083 | Plasma Protein Binding (PPB): | 56.25% |
Volume Distribution (VD): | 0.681 | Fu: | 29.84% |
CYP1A2-inhibitor: | 0.354 | CYP1A2-substrate: | 0.398 |
CYP2C19-inhibitor: | 0.105 | CYP2C19-substrate: | 0.093 |
CYP2C9-inhibitor: | 0.058 | CYP2C9-substrate: | 0.664 |
CYP2D6-inhibitor: | 0.213 | CYP2D6-substrate: | 0.648 |
CYP3A4-inhibitor: | 0.027 | CYP3A4-substrate: | 0.201 |
Clearance (CL): | 19.007 | Half-life (T1/2): | 0.93 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.035 |
Drug-inuced Liver Injury (DILI): | 0.058 | AMES Toxicity: | 0.62 |
Rat Oral Acute Toxicity: | 0.898 | Maximum Recommended Daily Dose: | 0.022 |
Skin Sensitization: | 0.933 | Carcinogencity: | 0.726 |
Eye Corrosion: | 0.983 | Eye Irritation: | 0.991 |
Respiratory Toxicity: | 0.906 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000028 | 0.571 | D07HBX | 0.531 | ||||
ENC000404 | 0.533 | D03UOT | 0.375 | ||||
ENC000060 | 0.533 | D0T7OW | 0.368 | ||||
ENC000033 | 0.516 | D05OIS | 0.364 | ||||
ENC000166 | 0.516 | D0F5ZM | 0.362 | ||||
ENC000754 | 0.515 | D07MOX | 0.350 | ||||
ENC005498 | 0.515 | D0V9EN | 0.326 | ||||
ENC000409 | 0.486 | D04PHC | 0.326 | ||||
ENC000108 | 0.485 | D0N3UL | 0.311 | ||||
ENC000683 | 0.474 | D08HVR | 0.311 |